Heterocephalus glaber (naked mole-rat): 101712867
Help
Entry
101712867 CDS
T02812
Symbol
Casp3, Caspase-3
Name
(RefSeq) caspase 3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
hgl
Heterocephalus glaber (naked mole-rat)
Pathway
hgl01524
Platinum drug resistance
hgl04010
MAPK signaling pathway
hgl04115
p53 signaling pathway
hgl04148
Efferocytosis
hgl04210
Apoptosis
hgl04215
Apoptosis - multiple species
hgl04623
Cytosolic DNA-sensing pathway
hgl04650
Natural killer cell mediated cytotoxicity
hgl04657
IL-17 signaling pathway
hgl04668
TNF signaling pathway
hgl04726
Serotonergic synapse
hgl04932
Non-alcoholic fatty liver disease
hgl04933
AGE-RAGE signaling pathway in diabetic complications
hgl04936
Alcoholic liver disease
hgl05010
Alzheimer disease
hgl05012
Parkinson disease
hgl05014
Amyotrophic lateral sclerosis
hgl05016
Huntington disease
hgl05020
Prion disease
hgl05022
Pathways of neurodegeneration - multiple diseases
hgl05132
Salmonella infection
hgl05133
Pertussis
hgl05134
Legionellosis
hgl05145
Toxoplasmosis
hgl05146
Amoebiasis
hgl05152
Tuberculosis
hgl05160
Hepatitis C
hgl05161
Hepatitis B
hgl05162
Measles
hgl05163
Human cytomegalovirus infection
hgl05164
Influenza A
hgl05165
Human papillomavirus infection
hgl05167
Kaposi sarcoma-associated herpesvirus infection
hgl05168
Herpes simplex virus 1 infection
hgl05169
Epstein-Barr virus infection
hgl05170
Human immunodeficiency virus 1 infection
hgl05200
Pathways in cancer
hgl05203
Viral carcinogenesis
hgl05205
Proteoglycans in cancer
hgl05206
MicroRNAs in cancer
hgl05210
Colorectal cancer
hgl05222
Small cell lung cancer
hgl05416
Viral myocarditis
hgl05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
hgl00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101712867 (Casp3)
04668 TNF signaling pathway
101712867 (Casp3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
101712867 (Casp3)
09143 Cell growth and death
04210 Apoptosis
101712867 (Casp3)
04215 Apoptosis - multiple species
101712867 (Casp3)
04115 p53 signaling pathway
101712867 (Casp3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
101712867 (Casp3)
04650 Natural killer cell mediated cytotoxicity
101712867 (Casp3)
04657 IL-17 signaling pathway
101712867 (Casp3)
09156 Nervous system
04726 Serotonergic synapse
101712867 (Casp3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
101712867 (Casp3)
05206 MicroRNAs in cancer
101712867 (Casp3)
05205 Proteoglycans in cancer
101712867 (Casp3)
05203 Viral carcinogenesis
101712867 (Casp3)
09162 Cancer: specific types
05210 Colorectal cancer
101712867 (Casp3)
05222 Small cell lung cancer
101712867 (Casp3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
101712867 (Casp3)
05161 Hepatitis B
101712867 (Casp3)
05160 Hepatitis C
101712867 (Casp3)
05164 Influenza A
101712867 (Casp3)
05162 Measles
101712867 (Casp3)
05168 Herpes simplex virus 1 infection
101712867 (Casp3)
05163 Human cytomegalovirus infection
101712867 (Casp3)
05167 Kaposi sarcoma-associated herpesvirus infection
101712867 (Casp3)
05169 Epstein-Barr virus infection
101712867 (Casp3)
05165 Human papillomavirus infection
101712867 (Casp3)
09171 Infectious disease: bacterial
05132 Salmonella infection
101712867 (Casp3)
05133 Pertussis
101712867 (Casp3)
05134 Legionellosis
101712867 (Casp3)
05152 Tuberculosis
101712867 (Casp3)
09174 Infectious disease: parasitic
05146 Amoebiasis
101712867 (Casp3)
05145 Toxoplasmosis
101712867 (Casp3)
09164 Neurodegenerative disease
05010 Alzheimer disease
101712867 (Casp3)
05012 Parkinson disease
101712867 (Casp3)
05014 Amyotrophic lateral sclerosis
101712867 (Casp3)
05016 Huntington disease
101712867 (Casp3)
05020 Prion disease
101712867 (Casp3)
05022 Pathways of neurodegeneration - multiple diseases
101712867 (Casp3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101712867 (Casp3)
05416 Viral myocarditis
101712867 (Casp3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
101712867 (Casp3)
04932 Non-alcoholic fatty liver disease
101712867 (Casp3)
04933 AGE-RAGE signaling pathway in diabetic complications
101712867 (Casp3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
101712867 (Casp3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
hgl01002
]
101712867 (Casp3)
Enzymes [BR:
hgl01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
101712867 (Casp3)
Peptidases and inhibitors [BR:
hgl01002
]
Cysteine peptidases
Family C14: caspase family
101712867 (Casp3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
101712867
NCBI-ProteinID:
XP_004853153
LinkDB
All DBs
Position
Un
AA seq
244 aa
AA seq
DB search
MWQYFPFCKVAHKPASEINHLITQLHGMSARSGTDVDAANLRETFMNLKYEVRNKNDLTR
EEIVELMCNVSKEDHSKRSSFICVILSHGEEGIIFGTNGPIDLKILTKFFRGDLCRSLAG
KPKLFVIQXXXXXXXDCGIETDSGIDDDMACQKIPVEADFLYAYSTAPGYYSWRNSKDGS
WFIQSLCAMVKLYAHKLEFMHILTRVNQKVATEFESFSYDSTFHAKKQIPCIVSMLTKEL
YFYH
NT seq
735 nt
NT seq
+upstream
nt +downstream
nt
atgtggcagtattttccattctgcaaagtggctcacaagccagcatcagaaatcaatcac
ctcatcacacagctgcatggaatgtcagctcgatctggtacagatgtagatgcagcaaac
ctcagagaaacatttatgaacttgaaatatgaagtgaggaataaaaatgatcttacacgg
gaagaaattgtggaattgatgtgcaatgtttctaaagaagatcacagcaaaaggagcagc
tttatttgtgtaattctaagccatggtgaagaaggaataatttttggaacaaatggaccc
attgacctgaaaatattaacaaaattcttcagaggggatctttgtagaagtctagctgga
aaacccaaacttttcgttattcagnnnnnnnnnnnnnnnnnnntggactgtggcattgag
acagacagtggtattgatgatgacatggcgtgccagaaaataccagtagaggctgacttc
ttgtatgcatattccacggcaccaggttactattcctggcgaaattcaaaggatggatcc
tggttcattcagtcactttgtgctatggtgaaattgtatgcacacaagcttgaatttatg
cacattcttactcgggttaaccagaaggtagcaacagaatttgaatccttttcctatgac
tccacttttcatgcaaagaaacaaattccatgtattgtgtccatgctcacaaaagaacta
tatttttatcactaa
DBGET
integrated database retrieval system